|
US7411075B1
(en)
|
2000-11-16 |
2008-08-12 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic form of atorvastatin calcium
|
|
IL156055A0
(en)
|
2000-11-30 |
2003-12-23 |
Teva Pharma |
Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms
|
|
US7501450B2
(en)
|
2000-11-30 |
2009-03-10 |
Teva Pharaceutical Industries Ltd. |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
|
|
NZ529557A
(en)
|
2001-06-29 |
2005-05-27 |
Warner Lambert Co |
Crystalline forms of `R-(R*,R*)!-2-(4-fluorophenyl)- beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- 'phenylamino)carbonyl!-1H-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
|
|
CZ296967B6
(cs)
|
2002-02-01 |
2006-08-16 |
Zentiva, A.S. |
Zpusob výroby amorfní formy hemivápenaté soli (3R,5R) 7-[3-fenyl-4-fenylkarbamoyl-2-(4-fluorfenyl)-5-isopropylpyrrol-1-yl]-3,5-dihydroxyheptanové kyseliny (atorvastatinu)
|
|
JP4422488B2
(ja)
|
2002-02-19 |
2010-02-24 |
テバ ファーマシューティカル インダストリーズ リミティド |
アトルバスタチンヘミカルシウム溶媒和物の脱溶媒和法及び有機溶媒を本質的に含まないアトルバスタチンヘミカルシウム
|
|
GB0218781D0
(en)
|
2002-08-13 |
2002-09-18 |
Astrazeneca Ab |
Chemical process
|
|
GB0312896D0
(en)
|
2003-06-05 |
2003-07-09 |
Astrazeneca Ab |
Chemical process
|
|
US7790197B2
(en)
|
2003-06-09 |
2010-09-07 |
Warner-Lambert Company Llc |
Pharmaceutical compositions of atorvastatin
|
|
US7655692B2
(en)
|
2003-06-12 |
2010-02-02 |
Pfizer Inc. |
Process for forming amorphous atorvastatin
|
|
US20050271717A1
(en)
|
2003-06-12 |
2005-12-08 |
Alfred Berchielli |
Pharmaceutical compositions of atorvastatin
|
|
AU2003247327A1
(en)
*
|
2003-07-15 |
2005-01-28 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S. |
Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form
|
|
UY28501A1
(es)
|
2003-09-10 |
2005-04-29 |
Astrazeneca Uk Ltd |
Compuestos químicos
|
|
GB0324791D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Chemical process
|
|
CZ298382B6
(cs)
*
|
2004-03-10 |
2007-09-12 |
Zentiva, A. S. |
Zpusob prípravy amorfní formy hemivápenaté soli atorvastatinu a její stabilizace
|
|
NO330092B1
(no)
*
|
2004-03-17 |
2011-02-14 |
Ranbaxy Lab Ltd |
Fremgangsmate for fremstilling av atorvastatin-kalsium i amorf form
|
|
BRPI0510713A
(pt)
|
2004-05-05 |
2007-11-20 |
Pfizer Prod Inc |
formas de sal de ácido [r-(r*,r*)]-2-(4-fluorofenil)-beta, delta-diidróxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)ca rbonil]-1h-pirrol-1- heptanóico
|
|
EP1771412A2
(en)
|
2004-07-20 |
2007-04-11 |
Warner-Lambert Company LLC |
Crystalline forms of [r-(r*)]-2-(4-fluorophenyl)-bet a,gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid calcium salt (2:1)
|
|
WO2006021969A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Biocon Limited |
Process for atorvastatin calcium amorphous
|
|
EP1793815A4
(en)
|
2004-09-30 |
2010-12-29 |
Reddys Lab Ltd Dr |
AMORPHES ATORVASTATINCALCIUM
|
|
NZ554541A
(en)
|
2004-10-28 |
2011-01-28 |
Warner Lambert Co |
Process for forming amorphous atorvastatin
|
|
WO2006048888A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Jubilant Organosys Limited |
Novel process for the preparation of amorphous atorvastatin calcium salt
|
|
ES2263370B1
(es)
*
|
2005-02-16 |
2007-12-01 |
Ercros Industrial, S.A. |
Atorvastatina calcica amorfa estabilizada y procedimiento para su obtencion.
|
|
WO2007052296A2
(en)
*
|
2005-08-23 |
2007-05-10 |
Kopran Research Laboratories Ltd |
A process of preparing amorphous atorvastatin calcium
|
|
ES2270722B1
(es)
*
|
2005-09-15 |
2008-03-01 |
Ercros Industrial, S.A. |
Procedimiento para la obtencion de atorvastatina calcica amorfa.
|
|
CA2547216A1
(en)
|
2005-09-21 |
2007-03-21 |
Renuka D. Reddy |
Process for annealing amorphous atorvastatin
|
|
ES2304335T3
(es)
|
2005-11-21 |
2010-05-19 |
Warner-Lambert Company Llc |
Formas nuevas del acido (r-(r*,r*))-2-(4-fluorofenil)-b,b-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)1h-pirrol-1-heptanoico, de magnesio.
|
|
EP1954653A4
(en)
*
|
2005-11-23 |
2010-11-03 |
Merck Sharp & Dohme |
METHOD FOR PRODUCING AN AMORPHANT SOLID FOR WATER-INSOLUBLE PHARMACEUTICALS
|
|
US20100260851A1
(en)
*
|
2007-07-11 |
2010-10-14 |
Actavis Group Ptc Ehf |
Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
|
|
WO2009082362A1
(en)
*
|
2007-11-05 |
2009-07-02 |
Ulkar Kimya San. Ve Tic. A.S. |
A method for producing statins in pure form
|
|
EP2075246A1
(en)
|
2007-12-27 |
2009-07-01 |
M. J. Institute of Research |
A process for preparation of amorphous form of atorvastatin hemi-calcium salt
|
|
WO2009090544A2
(en)
*
|
2008-01-16 |
2009-07-23 |
Matrix Laboratories Limited |
Process for producing amorphous atorvastatin calcium
|
|
WO2009139730A1
(en)
*
|
2008-05-13 |
2009-11-19 |
Ulkar Kimya San. Ve Tic. A.S. |
Preparation of novel non-crystalline forms of atorvastatin calcium
|
|
CN113321607A
(zh)
*
|
2020-02-28 |
2021-08-31 |
北京福元医药股份有限公司沧州分公司 |
一种阿托伐他汀钙中间体的纯化方法
|
|
CN114213270B
(zh)
*
|
2021-12-17 |
2024-05-28 |
江苏阿尔法药业股份有限公司 |
一种利用连续流微通道反应器合成阿托伐他汀钙中间体的方法
|